Deletion of the adenosine A

Animals Blood Pressure / physiology Disease Models, Animal Mice Mice, Knockout Peritonitis / genetics Receptor, Adenosine A2A / genetics Sepsis / genetics Survival Rate
A2A receptor Adenosine Bacterial load Endothelial damage Immune response Sepsis

Journal

Purinergic signalling
ISSN: 1573-9546
Titre abrégé: Purinergic Signal
Pays: Netherlands
ID NLM: 101250499

Informations de publication

Date de publication:
09 2020
Historique:
received: 30 05 2020
accepted: 28 07 2020
pubmed: 19 8 2020
medline: 19 8 2021
entrez: 19 8 2020
Statut: ppublish

Résumé

We aim to investigate the role of A

Identifiants

DOI: 10.1007/s11302-020-09719-w PMID: 32808144 PMC: PMC7524982
pubmed: 32808144
doi: 10.1007/s11302-020-09719-w
pii: 10.1007/s11302-020-09719-w
pmc: PMC7524982
doi:

Substances chimiques

Receptor, Adenosine A2A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

427-437

Références

Am J Physiol Regul Integr Comp Physiol. 2006 Oct;291(4):R959-69
pubmed: 16728466
Crit Care Med. 2005 Apr;33(4):780-6
pubmed: 15818105
Immunol Lett. 2019 Jan;205:9-15
pubmed: 29702147
J Immunol. 1996 Nov 15;157(10):4634-40
pubmed: 8906843
BMC Infect Dis. 2008 Oct 20;8:141
pubmed: 18937852
Cytokine. 2016 Dec;88:126-135
pubmed: 27599258
J Immunol. 2000 Jan 1;164(1):436-42
pubmed: 10605040
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1655-60
pubmed: 19749167
Lancet Infect Dis. 2013 Mar;13(3):260-8
pubmed: 23427891
Mol Biol (Mosk). 2016 Mar-Apr;50(2):231-45
pubmed: 27239843
Crit Care Med. 2001 Jul;29(7):1303-10
pubmed: 11445675
BMC Res Notes. 2014 Apr 12;7:233
pubmed: 24725742
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
J Immunol. 1999 Jan 1;162(1):392-9
pubmed: 9886412
J Vis Exp. 2012 May 11;(63):e3064
pubmed: 22617405
PLoS One. 2017 Oct 16;12(10):e0184520
pubmed: 29036167
J Immunol. 2010 Jul 1;185(1):542-50
pubmed: 20505145
J Smooth Muscle Res. 2007 Aug;43(4):117-37
pubmed: 17928746
Avicenna J Med Biotechnol. 2012 Jul;4(3):114-20
pubmed: 23407588
Am J Physiol Renal Physiol. 2005 Aug;289(2):F369-76
pubmed: 15784841
Mol Pharmacol. 1999 Mar;55(3):614-24
pubmed: 10051547
Vet Clin Pathol. 2006 Dec;35(4):388-96
pubmed: 17123244
Crit Care Med. 2001 Apr;29(4):765-9
pubmed: 11373466
BMC Infect Dis. 2012 Dec 10;12:342
pubmed: 23217055
Mucosal Immunol. 2009 May;2(3):232-42
pubmed: 19262506
J Neurosci. 1999 Nov 1;19(21):9192-200
pubmed: 10531422
J Immunol Res. 2015;2015:510436
pubmed: 26258150
Blood. 2000 Oct 1;96(7):2584-91
pubmed: 11001915
J Hepatol. 2017 Oct;67(4):716-726
pubmed: 28554875
Shock. 2002 Jan;17(1):55-60
pubmed: 11795670
J Surg Res. 1998 Dec;80(2):357-64
pubmed: 9878338
Med Sci Monit. 2020 Jan 29;26:e919054
pubmed: 31992687
Crit Care Med. 2000 Aug;28(8):2729-32
pubmed: 10966242
Purinergic Signal. 2017 Mar;13(1):51-60
pubmed: 27696086
Circ Res. 2002 Mar 22;90(5):531-8
pubmed: 11909816
PLoS One. 2014 Dec 22;9(12):e115705
pubmed: 25531402
Nature. 2001 Dec 20-27;414(6866):916-20
pubmed: 11780065
Virulence. 2014 Jan 1;5(1):4-11
pubmed: 24335434
Arterioscler Thromb Vasc Biol. 2010 May;30(5):1000-6
pubmed: 20185792
J Infect Dis. 1999 Nov;180(5):1550-60
pubmed: 10515815
Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1411-6
pubmed: 15539423
Front Immunol. 2018 Apr 04;9:595
pubmed: 29670613
Shock. 2008 Oct;30 Suppl 1:53-9
pubmed: 18704008
Blood. 2007 Oct 1;110(7):2685-95
pubmed: 17525287
Crit Care Med. 2000 Sep;28(9):3198-202
pubmed: 11008982
J Infect Dis. 2004 May 15;189(10):1897-904
pubmed: 15122527
Trends Microbiol. 2011 Apr;19(4):198-208
pubmed: 21296575
Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):856-64
pubmed: 22423037
J Immunol. 2006 May 1;176(9):5616-26
pubmed: 16622031
Crit Care Med. 2007 Jun;35(6):1464-9
pubmed: 17452928
Shock. 2001 Sep;16(3):196-202
pubmed: 11531021
Arthritis Res Ther. 2011;13(6):R197
pubmed: 22146575
J Immunol. 2001 Oct 1;167(7):4026-32
pubmed: 11564822
Virulence. 2014 Jan 1;5(1):73-9
pubmed: 24067428
J Immunol. 2005 Jan 15;174(2):1073-80
pubmed: 15634932
J Anat. 2008 Jan;212(1):31-41
pubmed: 18067546
Cardiovasc Res. 2003 Oct 15;60(1):49-57
pubmed: 14522406
Shock. 2011 Apr;35(4):382-7
pubmed: 21192284
J Immunol. 2011 Feb 15;186(4):2444-53
pubmed: 21242513

Auteurs

Miguel Meriño (M)

Vascular Physiology Laboratory, Group of Investigation in Tumor Angiogenesis (GIANT), Department of Basic Sciences, Faculty of Sciences, University of Bío-Bío, 3780000, Chillán, Chile.
Facultad de Ciencias de la Salud, Universidad Adventista de Chile, Chillan, Chile.

Sebastián San Martín (SS)

Biomedical Research Centre, School of Medicine, Universidad de Valparaíso, Valparaíso, Chile.
Group of Research and Innovation in Vascular Health (GRIVAS Health), Chillán, Chile.

Pedro Sandaña (P)

Anatomo-pathology Service, Clinical Hospital Herminda Martín, Chillán, Chile.
Universidad Católica de la Santísima Concepción, Concepción, Chile.

Kurt Herlitz (K)

Vascular Physiology Laboratory, Group of Investigation in Tumor Angiogenesis (GIANT), Department of Basic Sciences, Faculty of Sciences, University of Bío-Bío, 3780000, Chillán, Chile.

Claudio Aguayo (C)

Group of Research and Innovation in Vascular Health (GRIVAS Health), Chillán, Chile.
Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepción, Concepción, Chile.

Alejandro Godoy (A)

Group of Research and Innovation in Vascular Health (GRIVAS Health), Chillán, Chile.
Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.
Centro de Biología Celular y Biomedicina (CEBICEM), Universidad San Sebastián, Santiago, Chile.

Pablo Torres-Vergara (P)

Group of Research and Innovation in Vascular Health (GRIVAS Health), Chillán, Chile.
Departamento de Farmacia, Facultad de Farmacia, Universidad de Concepción, Concepción, Chile.

Marcelo Gonzalez (M)

Group of Research and Innovation in Vascular Health (GRIVAS Health), Chillán, Chile.
Laboratorio de Investigación Materno-Fetal (LIMaf), Department of Obstetrics and Gynecology, Faculty of Medicine, University of Concepción, Concepción, Chile.

Felipe Troncoso (F)

Vascular Physiology Laboratory, Group of Investigation in Tumor Angiogenesis (GIANT), Department of Basic Sciences, Faculty of Sciences, University of Bío-Bío, 3780000, Chillán, Chile.

Jesenia Acurio (J)

Vascular Physiology Laboratory, Group of Investigation in Tumor Angiogenesis (GIANT), Department of Basic Sciences, Faculty of Sciences, University of Bío-Bío, 3780000, Chillán, Chile.
Group of Research and Innovation in Vascular Health (GRIVAS Health), Chillán, Chile.

Carlos Escudero (C)

Vascular Physiology Laboratory, Group of Investigation in Tumor Angiogenesis (GIANT), Department of Basic Sciences, Faculty of Sciences, University of Bío-Bío, 3780000, Chillán, Chile. cescudero@ubiobio.cl.
Group of Research and Innovation in Vascular Health (GRIVAS Health), Chillán, Chile. cescudero@ubiobio.cl.
ORCID: 0000-0001-7688-4621

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Deletion of the adenosine A
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiologiques cardiovasculaires › Hémodynamique › Pression sanguine › Deletion of the adenosine A
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › Deletion of the adenosine A
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Deletion of the adenosine A
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Souris transgéniques › Souris knockout › Deletion of the adenosine A
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du péritoine › Péritonite › Deletion of the adenosine A
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs aux neuromédiateurs › Récepteurs purinergiques › Récepteurs purinergiques P1 › Récepteurs A2 à l'adénosine › Récepteur A2A à l'adénosine › Deletion of the adenosine A
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Sepsie › Deletion of the adenosine A
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Mortalité › Taux de survie › Deletion of the adenosine A